Risk factors
Ovid Therapeutics (OVID) risk factors
Item 1A of every Ovid Therapeutics Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors57 risks5 new14 dropped13 reworded
Ovid Therapeutics updated its financial figures showing cash of $90.4 million and an accumulated deficit of $321.7 million. New risk factors highlight macroeconomic uncertainties, potential FDA disruptions from government shutdowns, and patient population estimation challenges for brain disorders.
Filed Mar 18, 2026 - FY2024 10-K risk factors66 risks
Ovid Therapeutics faces significant cash burn, holding $53.1 million against an accumulated deficit of $304.3 million.
Filed Mar 11, 2025